Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco

J Infect Public Health. 2021 Mar;14(3):387-388. doi: 10.1016/j.jiph.2020.12.032. Epub 2021 Mar 4.

Authors

Mark A Fletcher¹, Hammam Haridy²

Affiliations

¹ Pfizer, Inc., Emerging Markets Medical Affairs, Paris, France. Electronic address: mark.a.fletcher@pfizer.com.
² Pfizer, Inc., Emerging Markets Medical Affairs, Dubai, United Arab Emirates. Electronic address: Hammam.Haridy@pfizer.com.

PMID: 33676195
DOI: 10.1016/j.jiph.2020.12.032

No abstract available

Publication types

Letter

MeSH terms

Humans
Infant
Morocco / epidemiology
Pneumococcal Infections* / epidemiology
Pneumococcal Infections* / prevention & control
Pneumococcal Vaccines*
Vaccines, Conjugate

Substances

Pneumococcal Vaccines
Vaccines, Conjugate